Endoscopic Breast Surgery in Treating Patients With Breast Cancer
NCT01222377 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2
Last updated 2014-02-06
Summary
RATIONALE: Endoscopic breast surgery (EBS) is a less invasive type of surgery for breast cancer and may have fewer side effects and improve recovery. PURPOSE: This clinical trial studies endoscopic breast surgery in treating patients with breast cancer.
Conditions
- Male Breast Cancer
- Recurrent Breast Cancer
- Stage IA Breast Cancer
- Stage IB Breast Cancer
- Stage II Breast Cancer
- Stage IIIA Breast Cancer
- Stage IIIB Breast Cancer
- Stage IIIC Breast Cancer
- Stage IV Breast Cancer
Interventions
- PROCEDURE
-
endoscopic surgery
Undergo endoscopic breast surgery
- PROCEDURE
-
quality-of-life assessment
Ancillary studies
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
University of Southern California
lead OTHER
Principal Investigators
-
Dennis Holmes · University of Southern California
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 15 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-09-30
- Primary Completion
- 2011-10-31
- Completion
- 2011-10-31
Countries
- United States
Study Locations
More Related Trials
-
Liposomal Doxorubicin Before Mastectomy in Treating Women With Invasive Breast Cancer
NCT00290732 ·Status: COMPLETED ·Phase: PHASE1
-
Fluorescence-guided Resection in Breast Cancer
NCT01110954 ·Status: TERMINATED ·Phase: PHASE2
-
Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery
NCT03317405 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By Surgery
NCT01705340 ·Status: TERMINATED ·Phase: PHASE1
-
Biology Guided Therapy for Breast Cancer for ER Positive
NCT04965688 ·Status: TERMINATED ·Phase: PHASE2
-
Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast Cancer
NCT03373708 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer
NCT03628066 ·Status: COMPLETED ·Phase: PHASE2
-
Bevacizumab and Letrozole in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer That Cannot Be Removed By Surgery
NCT00305825 ·Status: COMPLETED ·Phase: PHASE2
-
MK2206 in Combination With Anastrozole, Fulvestrant, or Anastrozole and Fulvestrant in Treating Postmenopausal Women With Metastatic Breast Cancer
NCT01344031 ·Status: COMPLETED ·Phase: PHASE1
-
A Single-Arm Pilot Study of Adjuvant Pembrolizumab Plus Trastuzumab in HER2+ Esophagogastric Tumors With Persistent Circulating Tumor DNA Following Curative Resection
NCT04510285 ·Status: TERMINATED ·Phase: PHASE2
-
Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
NCT01242800 ·Status: COMPLETED ·Phase: NA
-
Hypofractionated Radiation Therapy in Treating Participants With Breast Cancer Before Surgery
NCT03624478 ·Status: COMPLETED ·Phase: PHASE2
-
Epirubicin, Docetaxel, and Capecitabine in Treating Women With Stage IIIA or Stage IIIB Breast Cancer
NCT00645866 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen-Receptor Positive Primary Breast Cancer
NCT02296801 ·Status: COMPLETED ·Phase: PHASE2
-
Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer
NCT00002873 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study Of Changes In PD-L1 Expression During Preoperative Treatment With Nab-Paclitaxel And Pembrolizumab In Hormone Receptor-Positive Breast Cancer
NCT02999477 ·Status: COMPLETED ·Phase: PHASE1
-
Locally Advanced Breast Cancer: Individualized Treatment Based On Tumor Molecular Characteristics
NCT02297230 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors
NCT05262400 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
MK2206 and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Metastatic Breast Cancer
NCT01263145 ·Status: COMPLETED ·Phase: PHASE1
-
A Pre-Surgical PK Study of IM and Intraductally Delivered Fulvestrant
NCT02540330 ·Status: TERMINATED ·Phase: PHASE2
-
Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer
NCT01266642 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Effect of High Dose Vitamin D on Cancer Biomarkers and Breast Cancer Tumors
NCT02856503 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
MK-2206+Endocrine Therapy in Patients With Hormone Receptor-Positive Breast Cancer
NCT01240928 ·Status: WITHDRAWN ·Phase: PHASE1
-
Evaluate Trastuzumab Plus Standard Chemotherapy Given Before Surgery in Breast Cancer Patients With Low HER 2 Expression
NCT00944047 ·Status: COMPLETED ·Phase: PHASE2
-
Pegylated Liposomal Doxorubicin and Docetaxel in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery
NCT00524459 ·Status: TERMINATED ·Phase: PHASE2